Carmeconazole is a triazole fungicide developed by Kureha Corporation under the development code KNF-1934. It is characterized by low toxicity to humans and animals, excellent handling safety, and strong efficacy in controlling a wide range of plant diseases. In addition, it demonstrates high antibiotic activity against plant pathogens. Owing to these properties, Carmeconazole is well-suited for use as an active ingredient in agricultural and horticultural fungicides, plant growth regulators, and protective agents for industrial materials.
- Status: ISO (Provisionally Approved)
- IUPAC Name: methyl (2RS)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate
- CAS RN.: 2323565-15-5
- Activity: Fungicides (Triazole)
- Inchikey: JABCRSAQEYNUAS-UHFFFAOYSA-N
- Inchi: InChI=1S/C18H15Cl2N3O4/c1-26-17(24)18(25,9-23-11-21-10-22-23)15-7-6-14(8-16(15)20)27-13-4-2-12(19)3-5-13/h2-8,10-11,25H,9H2,1H3
Global Patent Protection
Kureha Corporation has filed an international patent application seeking protection for the active compound Carmeconazole. Subject to national phase entries and grant, the resulting patents are expected to provide protection until 2038.
About Kureha Corporation
Founded in 1944 and headquartered in Tokyo, Kureha Corporation is a global leader in specialty chemicals and advanced materials. The company is recognized as the world’s largest producer of polyphenylene sulfide (PPS) and a pioneer in polyglycolic acid (PGA) production. With a diverse portfolio spanning advanced materials, agrochemicals, food packaging, and specialty chemicals, Kureha continues to drive innovation, sustainability, and global expansion, reinforcing its position as a key player in the international chemical industry.
For more detailed information on Carmeconazole visit ChemRobotics AgroPat Ultimate Discovery Suite N Platform – ChemRobotics.com (Global Agrochemical Intelligence Database)
